Bucur SA
BUCV.BX operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of groceries and pharmaceutical products.
Business. BUCV.BX operates in the Food Retail & Distribution industry within the Consumer Non-Cyclicals sector, engaging in food and drug retailing activities. The company generates revenue through product sales, with key performance indicators including same-store sales growth, traffic, and average ticket size. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BUCV.BX operates in the Food Retail & Distribution industry within the Consumer Non-Cyclicals sector, engaging in food and drug retailing activities. The company generates revenue through product sales, with key performance indicators including same-store sales growth, traffic, and average ticket size. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
BUCV.BX maintains a strong liquidity position, with a current ratio of 5.97, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt of 22.37 million in cash and equivalents supports this, providing a buffer against near-term liabilities. The debt-to-equity ratio of 0.04 suggests a conservative capital structure, with minimal reliance on debt financing.
Profitability metrics for BUCV.BX are strong, with a return on equity (ROE) of 10.19% and a return on assets (ROA) of 9.75%. These figures exceed the typical thresholds for the Food Retail & Distribution industry, indicating efficient use of equity and assets to generate returns. The operating margin, derived from a gross profit of 11.31 million and operating income of 22.92 million, suggests a healthy margin structure.
The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification in the latest financial data. This concentration may expose the company to regional economic fluctuations, though the absence of disclosed geographic breakdowns limits further analysis.
BUCV.BX has demonstrated consistent revenue growth, with a total revenue of 32.69 million in the latest reporting period. While no specific growth rate is provided, the operating cash flow of 15.73 million and free cash flow of 2.63 million suggest a stable cash generation profile. The capital expenditure of -15.87 million indicates a net outflow, potentially related to asset purchases or maintenance.
Risk factors for BUCV.BX are currently low, with no immediate liquidity or dilution flags detected. The dilution potential is also low, with no significant changes in shares outstanding between basic and diluted shares. The company's conservative debt levels and strong liquidity position further mitigate financial risk.
Recent financial filings and transcripts do not indicate any material events or strategic shifts for BUCV.BX. The company appears to be operating within a stable financial framework, with no disclosed regulatory or operational disruptions.
- BUCV.BX has a strong liquidity position with a current ratio of 5.97 and 22.37 million in cash and equivalents.
- The company's ROE of 10.19% and ROA of 9.75% indicate efficient use of equity and assets.
- BUCV.BX maintains a conservative capital structure with a debt-to-equity ratio of 0.04.
- The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification.
- No immediate liquidity or dilution risks are present, and the company's financial risk profile is low.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- BUCV.BX Market data — financials · 2026-05-27